Global Spatial Omics Market

Global Spatial Omics Market Size, Share, Growth Analysis, By Technology(Spatial Transcriptomics, Spatial Genomics), By Product(Instruments, Consumables), By Workflow(Sample Preparation, Instrumental Analysis), By Sample Type(FFPE, Fresh Frozen), By End Users(Academic & Translational Research Institutes, Pharmaceutical and Biotechnology Companies) - Industry Forecast 2024-2031


Report ID: SQMIG35H2069 | Region: Global | Published Date: February, 2024
Pages: 242 | Tables: 142 | Figures: 80

Global Spatial Omics Market Insights

Spatial Omics Market size was valued at USD 244.36 million in 2019 and is poised to grow from USD 267 million in 2023 to USD 564.11 million by 2031, growing at a CAGR of 9.4% in the forecast period (2024-2031).

Through the spatial phenotyping method, Decoding the primary sequence of genes has been shifted to assessing the position and interaction of cell types and biomarkers. The rising prevalence of various types of genetic disorders, advances in sequencing technology world wide, and an increase in money spending on innovation for spatial omics research are all helping to increase the market growth.

Major companies in the market offer various solutions for spatial omics studies, Which helps in the quantification of around 1,800 RNA targets. Spatial OMICS blends the molecular analysis with spatial information on the cell within the tissue. The spatial pattern of the genome has been identified for the treatment of various diseases because of that spatial information is being used as a diagnostic biomarker for identifying the medical condition. This technology is providing a help tool to understand important mechanisms such as tissue organisation or cell regulation in the body.

US Spatial Omics Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Spatial Omics Market size was valued at USD 244.36 million in 2019 and is poised to grow from USD 267 million in 2023 to USD 564.11 million by 2031, growing at a CAGR of 9.4% in the forecast period (2024-2031).

Spatial omics market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. '10x Genomics', 'NanoString Technologies', 'Ilumina', 'Fluidigm Corporation', 'Akoya Biosciences (formerly PerkinElmer)', 'Agilent Technologies', 'Ultivue Inc.', 'S2 Genomics, Inc.', 'RareCyte, Inc.', 'ZEISS Group', 'Miltenyi Biotec', 'Bio-Techne Corporation', 'Spatial Transcriptomics', 'Visiopharm', 'Indica Labs, Inc.', 'Miroculus, Inc.', 'Bio-Rad Laboratories, Inc.', 'Luminex Corporation', 'Oxford Nanopore Technologies', 'Takara Bio Inc.', 'In September 2022, vizgen announced the launch of the MERSCOPE Protein Co-detection Kit, enabling subcellular spatial multi-omics measurement with the simultaneous detection of RNA and proteins during a standard MERFISH experiment.', 'In June 2022, Vizgen Showcases Expansion of MERSCOPE™ In Situ Single-Cell Spatial Genomics Platform Capabilities at AGBT.'

Due to some uncertainty many people have various diseases that transfer from one generation to another generation. Humans want to identify these types of disorders with the help of osmic Technology. Such types of factors increased the demand for spatial osmic tools.

The spatial omics technique used for detecting the mechanisms that govern the specific cell interactions at the tumour boundary. This novel technique offers an opportunity to be better helpful in the early detection of malignancy.

North America held the largest share of the global spatial omics market in 2021. This is due to the increasing prevalence of cancer, increasing demand for personalized medicine, well developed healthcare facilities in the North America region and availability of new diagnostic techniques. Due to cancer and other metabolic, autoimmune, and inflammatory disorders morbidity and mortality rates are increased and have increased demand for developing novel therapies that will increase the market growth in these regions.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Spatial Omics Market

Product ID: SQMIG35H2069

$5,300
BUY NOW GET FREE SAMPLE